Technology | January 21, 2014

HA85 PUR Relief is first FDA-registered skin care product for chemotherapy, radiation burns

American MD Labs HA85 PUR Relief Radiation Therapy

January 21, 2013 — American MD Labs’ HA85 PUR Relief skin care products are formulated to soothe symptoms related to chemotherapy and radiation treatment such as extremely dry skin, burns and muscle pain. 
 
HA85 PUR Relief contains hyaluronan, a naturally occurring polysaccharide that repairs skin tissues by embedding cells and fibrous constituents such as collagen and elastin. Hyaluronan binds 1,000 times its weight in water, which can contribute to skin tissue hydration. HA85 PUR Relief uses three different molecular weights of hyaluronan: 1 million daltons, 50,000 daltons and 5,000 daltons, which work on, under and deep under the surface of the skin, respectively. 
 
HA85 PUR Relief combines peptide technology with quaternary ammines to restore cellular membrane balance and treat radiation burns. HA85 PUR Relief’s key ingredients are designed to mimic the skin’s structure and auto-adjust pH to optimize production of enzymes that naturally heal wounds and promote skin homeostasis. 
 
Allantoin works as an anti-irritant and skin protectant, increases water content of the extracellular matrix and promotes cell replication. 
 
HA85 PUR Relief endeavors to provide deep hydration, relief and protection before, during and after treatment. The HA85 PUR Relief Professional Series will be available in both gel and spray applications and are water-free.
 
For more information: purrelief.com

Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now